An italian biopharmaceutical company
The company is focused on the discovery, development and commercialization of monoclonal antibodies
MP-PN-2
Cell surface component
The target is a high mw membrane protein of yet unknown function, that is expressed in cutaneous melanoma and some types of sarcoma.
Besides its use as a diagnostic tool, MP-PN-2 can be exploited as a therapeutic antibody.
Subscribe to Rss Feed
ShareMediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
